FDA Rejects Lilly’s Alzheimer’s Drug Candidate, Seeks More Data

Byadmin

Jan 20, 2023 4523.TO, Alzheimer's disease, Alzheimers, banking, Banking/Credit, BIIB, Biogen, C&E Industry News Filter, Candidate, Commercial Banking, Content Types, corporate, Corporate/Industrial News, Credit, data, Dementia, drug, Eisai, Eli Lilly, Factiva Filters, FDA, Financial Services, general news, government policies, health, healthcare, Healthcare/Life Sciences, industrial news, JP:4523, life sciences, Lillys, LLY, Medical Conditions, medications, Mental Disorders, Neurodegenerative Disease Drugs, new products, New Products/Services, pharmaceuticals, political, Political/General News, product, Product/Service Approvals, Products, Products/Services, regulation, Regulation/Government Policy, rejects, seeks, service approvals, services, specialized drugs, Specialized Drugs/Medications, SYND, WSJ-PRO-WSJ.com, wsjhealth

FDA Rejects Lilly's Alzheimer's Drug Candidate, Seeks More Data

Setback could delay potential industrial introduction of drug referred to as donanemab by at the very least quite a few months

#Fda #Rejects #Lillys #Alzheimers #Drug #Applicant #Seeks #Facts

Related

Post navigation

Google parent Alphabet to cut 12,000 jobs, citing ‘economic reality’
Fed Governor Waller backs quarter-point interest rate hike at next meeting

By admin

Related Post

Business

Google News

Feb 2, 2023 admin

Business

Dow Jones Dips As Apple Helps Nasdaq Fly; Meta Stock Rockets After Mark Zuckerberg ‘Surprise’

Feb 2, 2023 admin

Business

Meta Platforms Shares Surge on Cost Cuts, Stock Buyback

Feb 2, 2023 admin

Leave a Reply Cancel reply
Your email address will not be published. Required fields are marked *
Comment *
Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Search
Recent Posts
Google News

Dow Jones Dips As Apple Helps Nasdaq Fly; Meta Stock Rockets After Mark Zuckerberg ‘Surprise’

Meta Platforms Shares Surge on Cost Cuts, Stock Buyback

FDA approves GSK’s anemia drug with safety warning — after batting back similar drugs

US weekly jobless claims drop to nine-month low; productivity gains speed

Recent Comments
No comments to show.

Byadmin

Setback could delay potential industrial introduction of drug referred to as donanemab by at the very least quite a few months

Related

By admin

Related Post

Leave a Reply Cancel reply

You missed